Appleton Partners Inc Amgen Inc Transaction History

Appleton Partners Inc

  • $1.36 Billion
  • Q3 2024

A detailed history of Appleton Partners Inc transactions in Amgen Inc stock. As of the latest transaction made, Appleton Partners Inc holds 19,572 shares of AMGN stock, worth $6.27 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
19,572
Previous 20,096 2.61%
Holding current value
$6.27 Million
Previous $6.28 Million 0.43%
% of portfolio
0.46%
Previous 0.48%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024
SELL
$309.38 - $337.38 $162,115 - $176,787
-524 Reduced 2.61%
19,572 $6.31 Million
Q2 2024

Jul 02, 2024
SELL
$262.75 - $319.31 $57,016 - $69,290
-217 Reduced 1.07%
20,096 $6.28 Million
Q1 2024

Apr 01, 2024
BUY
$268.87 - $324.56 $75,014 - $90,552
279 Added 1.39%
20,313 $5.78 Million
Q4 2023

Jan 02, 2024
SELL
$255.7 - $288.46 $359,258 - $405,286
-1,405 Reduced 6.55%
20,034 $5.77 Million
Q3 2023

Oct 03, 2023
SELL
$218.65 - $271.46 $372,360 - $462,296
-1,703 Reduced 7.36%
21,439 $5.76 Million
Q2 2023

Jul 10, 2023
SELL
$214.27 - $253.37 $30,212 - $35,725
-141 Reduced 0.61%
23,142 $5.14 Million
Q1 2023

Apr 10, 2023
SELL
$225.79 - $275.2 $172,729 - $210,528
-765 Reduced 3.18%
23,283 $5.63 Million
Q4 2022

Jan 19, 2023
SELL
$229.03 - $291.01 $1.07 Million - $1.36 Million
-4,660 Reduced 16.23%
24,048 $6.32 Million
Q3 2022

Oct 27, 2022
BUY
$224.46 - $253.15 $153,306 - $172,901
683 Added 2.44%
28,708 $6.47 Million
Q2 2022

Jul 08, 2022
BUY
$230.71 - $256.74 $152,268 - $169,448
660 Added 2.41%
28,025 $6.82 Million
Q1 2022

Apr 05, 2022
SELL
$219.27 - $242.57 $56,571 - $62,583
-258 Reduced 0.93%
27,365 $6.62 Million
Q4 2021

Feb 03, 2022
BUY
$198.88 - $227.6 $108,787 - $124,497
547 Added 2.02%
27,623 $6.21 Million
Q3 2021

Oct 14, 2021
BUY
$212.27 - $248.7 $134,791 - $157,924
635 Added 2.4%
27,076 $5.76 Million
Q2 2021

Jul 07, 2021
BUY
$233.58 - $259.14 $104,410 - $115,835
447 Added 1.72%
26,441 $6.45 Million
Q1 2021

Apr 19, 2021
BUY
$221.91 - $258.6 $97,196 - $113,266
438 Added 1.71%
25,994 $6.47 Million
Q4 2020

Jan 19, 2021
SELL
$216.38 - $257.67 $35,702 - $42,515
-165 Reduced 0.64%
25,556 $5.88 Million
Q3 2020

Oct 14, 2020
BUY
$234.65 - $260.95 $122,252 - $135,954
521 Added 2.07%
25,721 $6.54 Million
Q2 2020

Aug 14, 2020
SELL
$197.81 - $242.74 $159,830 - $196,133
-808 Reduced 3.11%
25,200 $5.94 Million
Q1 2020

May 04, 2020
SELL
$182.24 - $241.7 $106,245 - $140,911
-583 Reduced 2.19%
26,008 $5.27 Million
Q4 2019

Jan 13, 2020
BUY
$189.21 - $243.2 $553,439 - $711,360
2,925 Added 12.36%
26,591 $6.41 Million
Q3 2019

Nov 04, 2019
SELL
$174.11 - $208.62 $127,100 - $152,292
-730 Reduced 2.99%
23,666 $4.58 Million
Q2 2019

Jul 25, 2019
SELL
$166.7 - $195.41 $9,335 - $10,942
-56 Reduced 0.23%
24,396 $4.5 Million
Q1 2019

Apr 17, 2019
BUY
$180.87 - $203.88 $84,104 - $94,804
465 Added 1.94%
24,452 $4.65 Million
Q4 2018

Jan 17, 2019
BUY
$178.4 - $208.25 $557,856 - $651,197
3,127 Added 14.99%
23,987 $4.67 Million
Q3 2018

Oct 09, 2018
BUY
$185.29 - $208.89 $50,028 - $56,400
270 Added 1.31%
20,860 $4.32 Million
Q2 2018

Aug 08, 2018
BUY
$166.05 - $186.51 $271,823 - $305,316
1,637 Added 8.64%
20,590 $3.8 Million
Q1 2018

Apr 11, 2018
BUY
$169.43 - $198.0 $155,028 - $181,170
915 Added 5.07%
18,953 $3.23 Million
Q4 2017

Jan 12, 2018
BUY
$168.79 - $188.59 $249,471 - $278,736
1,478 Added 8.93%
18,038 $3.14 Million
Q3 2017

Oct 12, 2017
BUY
$167.29 - $191.0 $2.77 Million - $3.16 Million
16,560
16,560 $3.09 Million

Others Institutions Holding AMGN

# of Institutions
3,080
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Appleton Partners Inc Portfolio

Follow Appleton Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email